Abstract:Background Urothelial bladder cancer (BCa) is a common malignant tumor of the urinary system. It has been identified that exosomal miRNAs contribute to the development of BCa. However, its significance and mechanism in the malignant biological behavior of BCa remain unclear. In this study, the influence of exosomal miRNAs on BCa progression was investigated. Methods High-throughput sequencing was conducted to analyze the microRNA-expression profile in urinary exosomes to screen out the key miRNA of muscle-invasive bladder cancer (MIBC). Then, candidate miRNA expression was verified and validated in urinary exosomes and tissue samples. To address the potential role of the candidate miRNA, we overexpressed and knocked down the candidate miRNA and explored its activity in BCa cell lines. Furthermore, the target gene of the selected miRNA was predicted and validated. Results The expression profile of miRNAs revealed increased expression of miR-17-5p in MIBC urinary exosomes, and this was later confirmed in urinary exosomes and tissue samples. Cell function studies revealed that exosomal miR-17-5p significantly promoted the growth and invasion of BCa cells. Bioinformatics and luciferase experiments demonstrated that the ARID4B mRNA 3′ UTR might be the binding site for miR-17-5p. Low ARID4B levels were linked to high-grade BCa patients and were associated with a better prognosis. Conclusion Elevated miR-17-5p contributes to BCa progression by targeting ARID4B and influencing the immune system. Based on these findings, miR-17-5p has the potential to be a new therapeutic target for the treatment of BCa. Macro abstract Our data revealed that miR-17-5p is enriched in the urine exosomes of muscle-invasive bladder cancer. Further investigation showed that miR-17-5p functions as a tumor promoter both in vitro and in vivo, possibly by targeting ARID4B and influencing the immune system. These findings imply that miR-17-5p might be a novel target for bladder cancer treatment.

Urinary exosomal miR-17-5p accelerates bladder cancer invasion by repressing its target gene ARID4B and regulating the immune microenvironment

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

Exosomal Mir-93-5p As an Important Driver of Bladder Cancer Progression.

Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression

Urinary Exosomal Lnc-Taf12-2:1 Promotes Bladder Cancer Progression Through the Mir-7847-3p/asb12 Regulatory Axis

Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance

Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.

Exosome–transmitted Microrna‐133b Inhibited Bladder Cancer Proliferation by Upregulating Dual‐specificity Protein Phosphatase 1

MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21

The Role of Exosomal Mir‐375‐3p: A Potential Suppressor in Bladder Cancer Via the Wnt/β‐catenin Pathway

miR-221-5p and miR-186-5p are the critical exosomal miRNAs in bladder cancer induced natural killer cells dysfunction

Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p

miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma

MicroRNAs in bladder cancer: expression profiles, biological functions, regulation, and clinical implications.

Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer

Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

MiRNA-217 Accelerates the Proliferation and Migration of Bladder Cancer Via Inhibiting KMT2D.

BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression

miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction

Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p